Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | May 10, 2012 at 4:14 PM EDT

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Jon C. Ogg | May 8, 2012 at 1:15 PM EDT

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a…

Douglas A. McIntyre | May 8, 2012 at 6:31 AM EDT

America Adjusts for Obesity

Authors of a new CDC study, widely covered in the press, reported that the number of Americans considered obese will rise…

Jon C. Ogg | May 7, 2012 at 4:47 PM EDT

Dendreon, When 200% Sales Growth Is Not Enough (DNDN)

AuthorDendreon Corporation (NASDAQ: DNDN) has reported its quarterly results and the reaction is a bit cool. This is growth of…

Jon C. Ogg | May 7, 2012 at 8:54 AM EDT

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired. …

Paul Ausick | May 3, 2012 at 2:33 PM EDT

Herbalife Sinks on Lack of Info (HLF, NUS)

Shares of Herbalife Ltd. (NYSE: HLF) are trading at about 9x average daily volume today following some weak answers on…

Jon C. Ogg | May 3, 2012 at 9:00 AM EDT

Another Medical Company Goes To Europe… Kensey Nash Buyout At All-Time High (KNSY)

Kensey Nash Corporation (NASDAQ: KNSY) is well-known for its regenerative tissue materials, but it is soon going to be known under…

Jon C. Ogg | May 2, 2012 at 1:31 PM EDT

Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) already had problems before a fund called Tang Capital accused it of being insolvent this…

Douglas A. McIntyre | Apr 28, 2012 at 10:54 AM EDT

Fast-Acting Erectile Dysfunction Drug Penetrates The Market

Men with erectile dysfunction can get relief twice as quickly as was possible in the past. VIVUS, Inc. (NASDAQ: VVUS)…

Paul Ausick | Apr 27, 2012 at 12:29 PM EDT

Allscripts Plunges on Perfect Storm of Bad News (MDRX)

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) fired its board chairman, saw three directors leave in protest, and announced the resignation…

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 26, 2012 at 11:13 AM EDT

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as…

Paul Ausick | Apr 23, 2012 at 3:23 PM EDT

Social Security, Medicare Still Going Broke

The annual report of the Trustees of the Social Security and Medicare trust funds has been released, and no matter…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

1 … 318 319 320 321 322 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

America Adjusts for Obesity

Dendreon, When 200% Sales Growth Is Not Enough (DNDN)

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Herbalife Sinks on Lack of Info (HLF, NUS)

Another Medical Company Goes To Europe… Kensey Nash Buyout At All-Time High (KNSY)

Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)

Fast-Acting Erectile Dysfunction Drug Penetrates The Market

Allscripts Plunges on Perfect Storm of Bad News (MDRX)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

Social Security, Medicare Still Going Broke

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

America Adjusts for Obesity

Dendreon, When 200% Sales Growth Is Not Enough (DNDN)

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Herbalife Sinks on Lack of Info (HLF, NUS)

Another Medical Company Goes To Europe… Kensey Nash Buyout At All-Time High (KNSY)

Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)

Fast-Acting Erectile Dysfunction Drug Penetrates The Market

Allscripts Plunges on Perfect Storm of Bad News (MDRX)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

Social Security, Medicare Still Going Broke

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up